Xeltis announced the official start of the European commercialization of aXess vascular access device for patients requiring hemod ...
Fluidx Medical Technology, Inc. announced results from a pivotal clinical trial evaluating the company’s GPX embolic device.
HistoSonics announced that it has received approval in Europe for its Edison system, enabling the commercialization of the ...
Vesalio announced the appointment of Greg Cook as Chief Commercial Officer, responsible for leading the company’s commercial ...
The Society for Cardiovascular Angiography and Interventions (SCAI) announced that a multisociety expert consensus statement ...
Delcath Systems, Inc., an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announ ...
Stereotaxis announced that it has completed its previously announced acquisition of Robocath, a Rouen, France-based developer ...
Maintenance of vascular access has long been the Achilles’ heel of patients undergoing hemodialysis (HD). Evolving from the direct cannulation of native vessels to highly morbid Teflon shunts, it wasn ...
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...
Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results